JPMorgan
http://www.jpmorgan.comJPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $1.5 trillion and operations in more than 50 countries. The firm is a leader in investment banking, financial services for consumers, small business and commercial banking, financial transaction processing, asset management, and private equity.
-
JP Morgan Downgrades Arena Pharmaceuticals (ARNA) to Neutral
-
Notable 52-Week High's and Low's of the Day 07/30: PWER, ARNA, SATC, TEN High; WFR, TNAV, BIOS, NVDA Low
-
Unusual 11 Mid-Day Movers 07/16: LSBX, ARNA, AVII, CYPB, SCHW, TSLA Higher; VVUS, JST, ROIAK, OREX, PLCM Lower
-
Notable Analyst Rating Changes 07/16: GS, JPM, ARNA, ADM Upgraded; VVUS, BP, RBA, OREX Downgraded
-
Morning Movers 7/16: LSBX, ARNA, AVII Higher; VVUS, JST, VRNM, BIOF, VIDE, PLCM Lower
-
Arena Pharmaceuticals (ARNA) 17% Higher Following Vivus's Qnexa Blow-up
-
Arena Pharmaceuticals (ARNA): Upgraded to Overweight at J.P. Morgan
-
J.P. Morgan on Biotechnology and Drugs Stocks; Upgrades ARNA, Cuts VVUS
-
Notable Analyst Rating Changes 07/02: BJ, ARNA, NI, CEDC Upgraded; GRMN, SWN, EQR Downgraded
-
Notable Analyst Rating Changes 12/17: NWSA, UNM, LNC, PTV Upgraded; ADP, AEM, FGXI, OC Downgrades
-
Unusual 11 Mid-Day Movers 3/30: PRSC, FAZ, SPRD, FXP Higher; LNC, ARNA, MTW, TRW Lower
